Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LY2525623 (IL-23 Antibody) Multiple-Dose Study in Adults With Plaque Psoriasis

NCT01018810 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01018810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01018810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LY2525623 (IL-23 Antibody) Multiple-Dose Study in Adults With Plaque Psoriasis
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2009
Completion date
August 31, 2010
Enrollment
8 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis